Bringing Cell and Gene Therapy to Africa
Revolutionary Cancer Treatment
Made in Africa
We strive to overcome diseases with unmet medical needs by developing accessible therapies. We have received approval from SAHPRA to start Africa’s first clinical trial with CAR T cells this year. We work closely with Miltenyi Biomedicine and using the CliniMACS Prodigy by Miltenyi Biotec. Our aim is to bring a wide range of cell and gene therapies to Africa, offering accessible therapies to both Africans and medical tourists.
Social Responsibility
At Capecell, we believe that Africans should be granted easier access to life saving cancer therapies.
We commit to an ethical, integrity-centric culture and are united by the vision that our work benefits South Africa and the continent.
By setting up a local, in-hospital manufacturing facility we have a grassroots approach to improving the quality of life for cancer patients.